ACAD
ACAD
NASDAQ · Biotechnology

Acadia Pharmaceuticals Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$22.09
+0.47 (+2.17%)
As of Jun 22, 9:55 PM ET ·
Analyst Consensus
Strong Buy
27
Analysts
High
Coverage
Buy 21 78%
Hold 5 19%
Sell 1 4%
Price Target
Analyst Price Target -19.0% upside
Low Target $12.70
Average Target $17.90
High Target $23.84
Current Price $22.09
Current
$22.09
Target
$17.90
$12.70 $17.90 avg $23.84
Scenario Analysis
Bear Case
$12.70
-42.5%
Low target
Base Case
$17.90
-19.0%
Avg target
Bull Case
$23.84
+7.9%
High target
Risk/Reward
0.2x
Unfavorable
Price in Context
52-Week High
$28.35
-22.1% from high
52-Week Low
$19.69
+12.2% from low
50-Day SMA
$25.91
-14.7% vs SMA
200-Day SMA
$23.44
-5.8% vs SMA
RSI (14)
42.4
Neutral
Target vs 52W High
$17.90
-36.9% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 78% $257.58 +12.0%
AMGN
Amgen Inc
 Hold 44 50% $190.87 -44.6%
GILD
Gilead Sciences Inc
 Strong Buy 39 82% $362.68 +190.4%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 40 83% $438.34 -6.1%
REGN
Regeneron Pharmaceuticals
 Buy 38 71% $76.80 -87.5%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 37 76% $102.31 -64.3%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -31.2%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -37.5%